tiprankstipranks
CVS Bay Area Inc. (JP:2687)
:2687
Japanese Market

CVS Bay Area Inc. (2687) AI Stock Analysis

0 Followers

Top Page

JP:2687

CVS Bay Area Inc.

(2687)

Select Model
Select Model
Select Model
Outperform 79 (OpenAI - 5.2)
Rating:79Outperform
Price Target:
¥562.00
▲(11.07% Upside)
Action:N/ADate:07/28/25
CVS Bay Area Inc. scores well due to strong financial performance and attractive valuation. The company's recovery in profitability and stable balance sheet are significant strengths. Technical indicators suggest stable momentum with potential for growth. However, challenges in cash flow management and debt levels require careful monitoring.
Positive Factors
Revenue Growth
A 4.03% year-over-year revenue increase reflects durable top-line recovery and expanding sales traction. Over a 2-6 month horizon sustained revenue growth supports reinvestment in operations, stabilizes planning, and reduces reliance on one-off margin improvements to drive profitability.
Negative Factors
Negative Free Cash Flow
Material negative free cash flow and an operating-cash-to-net-income ratio of 0.37 indicate cash generation lags accounting profits. Persisting FCF deficits may force external financing, constrain capex or dividends, and weaken financial flexibility over a multi-month horizon.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
A 4.03% year-over-year revenue increase reflects durable top-line recovery and expanding sales traction. Over a 2-6 month horizon sustained revenue growth supports reinvestment in operations, stabilizes planning, and reduces reliance on one-off margin improvements to drive profitability.
Read all positive factors

CVS Bay Area Inc. (2687) vs. iShares MSCI Japan ETF (EWJ)

CVS Bay Area Inc. Business Overview & Revenue Model

Company Description
CVS Bay Area Inc. operates convenience stores under the Lawson brand in Japan. The company also operates hotels under the BAY HOTEL brand name. In addition, it provides various manned front desk and reception/office butler services for companies a...
How the Company Makes Money
null...

CVS Bay Area Inc. Financial Statement Overview

Summary
CVS Bay Area Inc. has shown strong recovery in its income statement with significant revenue growth and improved profit margins. The balance sheet is stable with moderate leverage, but cash flow management remains a challenge with negative free cash flow. Overall, the company is on a positive trajectory, but attention to debt and cash flow is crucial.
Income Statement
85
Very Positive
Balance Sheet
78
Positive
Cash Flow
70
Positive
BreakdownTTMFeb 2025Feb 2024Feb 2023Feb 2022Feb 2021
Income Statement
Total Revenue7.90B7.82B7.52B6.93B7.21B7.32B
Gross Profit3.49B3.49B3.23B2.57B2.12B1.86B
EBITDA385.83M572.44M643.26M238.81M-160.49M-426.13M
Net Income241.02M1.12B697.62M-13.53M-831.52M-1.16B
Balance Sheet
Total Assets11.54B11.27B10.31B8.68B9.41B10.51B
Cash, Cash Equivalents and Short-Term Investments1.86B1.78B1.89B1.77B1.73B1.94B
Total Debt5.74B5.29B5.32B4.48B4.85B4.88B
Total Liabilities7.29B6.89B6.95B5.94B6.58B6.79B
Stockholders Equity4.25B4.38B3.36B2.74B2.83B3.72B
Cash Flow
Free Cash Flow0.00-1.08B-635.20M-196.02M-406.11M-559.42M
Operating Cash Flow0.00410.52M481.89M-172.53M-351.39M120.76M
Investing Cash Flow0.00-384.36M-1.08B654.76M232.76M-341.04M
Financing Cash Flow0.00-129.65M710.97M-442.98M-84.74M550.89M

CVS Bay Area Inc. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price506.00
Price Trends
50DMA
499.96
Positive
100DMA
503.99
Positive
200DMA
536.71
Negative
Market Momentum
MACD
1.92
Negative
RSI
59.37
Neutral
STOCH
67.46
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:2687, the sentiment is Positive. The current price of 506 is above the 20-day moving average (MA) of 492.85, above the 50-day MA of 499.96, and below the 200-day MA of 536.71, indicating a neutral trend. The MACD of 1.92 indicates Negative momentum. The RSI at 59.37 is Neutral, neither overbought nor oversold. The STOCH value of 67.46 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:2687.

CVS Bay Area Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
79
Outperform
¥2.52B16.774.73%2.93%-81.08%
78
Outperform
¥60.25B7.882.85%11.38%4.28%
76
Outperform
¥114.40B10.451.92%2.30%26.52%
75
Outperform
¥78.63B11.620.70%8.48%26.56%
69
Neutral
¥223.48B19.902.43%4.48%13.17%
66
Neutral
¥32.31B14.622.22%7.94%-8.55%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:2687
CVS Bay Area Inc.
486.00
-40.21
-7.64%
JP:3539
JM Holdings Co., Ltd.
1,537.00
370.77
31.79%
JP:7508
G-7 Holdings Inc.
1,357.00
63.04
4.87%
JP:7596
Uoriki Co., Ltd.
2,318.00
-50.63
-2.14%
JP:8194
Life Corporation
2,642.00
622.10
30.80%
JP:8198
Maxvalu Tokai Co., Ltd.
3,585.00
642.60
21.84%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 28, 2025